Clinical Trial Update: A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating safety, tolerability, and effectiveness of hydroxychloroquine and itraconazole in platinum-resistant epithelial ovarian cancer has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platinum-resistant Epithelial Ovarian Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Itraconazole (Itraconazole)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Platinum-resistant Epithelial Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED